Tolerance Bio, Inc. is a biopharmaceutical company developing thymus-based therapies and iPSC-based cell treatments for immune-mediated diseases like cancer, autoimmunity, and transplant rejection.

Tolerance Bio, Inc. is a biopharmaceutical company developing thymus-based therapies and iPSC-based cell treatments for immune-mediated diseases like cancer, autoimmunity, and transplant rejection.